The EGX chairmanship has decided to suspend the trading in shares of Nile Pharmaceuticals & Chemical Industries (NIPH) starting from today’s trading session until the NIPH’s budgeting for the fiscal year 2012-2013 would be submitted.
Additionally, the company has announced an invitation to attend the ordinary general Assembly’s meeting on Saturday March 17th so as to consider the accreditation of the NIPH’s budgeting project for the fiscal year 2012/2013.